1-64009249-A-G
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005012.4(ROR1):c.92-56A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00605 in 1,308,252 control chromosomes in the GnomAD database, including 419 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.030 ( 254 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 165 hom. )
Consequence
ROR1
NM_005012.4 intron
NM_005012.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.662
Genes affected
ROR1 (HGNC:10256): (receptor tyrosine kinase like orphan receptor 1) This gene encodes a receptor tyrosine kinase-like orphan receptor that modulates neurite growth in the central nervous system. The encoded protein is a glycosylated type I membrane protein that belongs to the ROR subfamily of cell surface receptors. It is a pseudokinase that lacks catalytic activity and may interact with the non-canonical Wnt signalling pathway. This gene is highly expressed during early embryonic development but expressed at very low levels in adult tissues. Increased expression of this gene is associated with B-cell chronic lymphocytic leukaemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 1-64009249-A-G is Benign according to our data. Variant chr1-64009249-A-G is described in ClinVar as [Benign]. Clinvar id is 1260821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.102 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ROR1 | NM_005012.4 | c.92-56A>G | intron_variant | Intron 1 of 8 | ENST00000371079.6 | NP_005003.2 | ||
ROR1 | NM_001083592.2 | c.92-56A>G | intron_variant | Intron 1 of 6 | NP_001077061.1 | |||
ROR1 | XM_011541526.2 | c.-98-56A>G | intron_variant | Intron 1 of 8 | XP_011539828.1 | |||
ROR1 | XM_017001377.2 | c.-250A>G | upstream_gene_variant | XP_016856866.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ROR1 | ENST00000371079.6 | c.92-56A>G | intron_variant | Intron 1 of 8 | 1 | NM_005012.4 | ENSP00000360120.1 | |||
ROR1 | ENST00000371080.5 | c.92-56A>G | intron_variant | Intron 1 of 6 | 1 | ENSP00000360121.1 | ||||
ROR1 | ENST00000482426.1 | n.126-56A>G | intron_variant | Intron 1 of 5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0297 AC: 4519AN: 151966Hom.: 254 Cov.: 32
GnomAD3 genomes
AF:
AC:
4519
AN:
151966
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00293 AC: 3382AN: 1156168Hom.: 165 AF XY: 0.00248 AC XY: 1465AN XY: 590856
GnomAD4 exome
AF:
AC:
3382
AN:
1156168
Hom.:
AF XY:
AC XY:
1465
AN XY:
590856
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0298 AC: 4530AN: 152084Hom.: 254 Cov.: 32 AF XY: 0.0288 AC XY: 2142AN XY: 74358
GnomAD4 genome
AF:
AC:
4530
AN:
152084
Hom.:
Cov.:
32
AF XY:
AC XY:
2142
AN XY:
74358
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
35
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
May 24, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at